In this study, patients with advanced solid tumors will undergo \[18F\]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
In this study, patients with advanced solid tumors will undergo \[18F\]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
-
Stanford University, Stanford, California, United States, 94305
Oregon Health and Science University, Portland, Oregon, United States, 97239
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
CellSight Technologies, Inc.,
Carina Mari Aparici, M.D., PRINCIPAL_INVESTIGATOR, Stanford University
Erik Mittra, M.D., PRINCIPAL_INVESTIGATOR, Oregon Health and Science University
Shivaani Kummar, M.D., PRINCIPAL_INVESTIGATOR, Oregon Health and Science University
2026-11-30